Skip to Main Content

Paper Details

APEX: a phase II randomised clinical trial evaluating the safety and preliminary efficacy of oral X-82 to treat exudative age-related macular degeneration.
Br J Ophthalmol
15
2021
Author NameAffiliation
Michael N Cohen
Michael N CohenTufts University School of Medicine
Philip J RosenfeldBascom Palmer Eye Institute, University of Miami Miller School of Medicine
  • 1 - 3

Datasets

Release 1.2